Real world experience of palbociclib in hormone receptor-positive metastatic breast cancer.

被引：3
|
作者：
Malik, Faizan
Ali, Naveed
Jafri, Syed Imran Mustafa
Sundermeyer, Mark L.
Seidman, Michael Jeffrey
Fidler, Christian Joseph
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e18094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18094
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Clinical Review on the Management of Hormone Receptor-Positive Metastatic Breast Cancer
    McAndrew, Nicholas P.
    Finn, Richard S.
    JCO ONCOLOGY PRACTICE, 2022, 18 (05) : 319 - 328
  • [42] Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
    Anishka D’Souza
    Darcy Spicer
    Janice Lu
    Journal of Hematology & Oncology, 11
  • [43] Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
    D'Souza, Anishka
    Spicer, Darcy
    Lu, Janice
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [44] Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience
    Pizzuti, Laura
    Giordano, Antonio
    Michelotti, Andrea
    Mazzotta, Marco
    Natoli, Clara
    Gamucci, Teresa
    De Angelis, Claudia
    Landucci, Elisabetta
    Diodati, Lucrezia
    Iezzi, Laura
    Mentuccia, Lucia
    Fabbri, Agnese
    Barba, Maddalena
    Sanguineti, Giuseppe
    Marchetti, Paolo
    Tomao, Silverio
    Mariani, Luciano
    Paris, Ida
    Lorusso, Vito
    Vallarelli, Simona
    Cassano, Alessandra
    Airoldi, Francesca
    Orlandi, Armando
    Moscetti, Luca
    Sergi, Domenico
    Sarobba, Maria Giuseppina
    Tonini, Giuseppe
    Santini, Daniele
    Sini, Valentina
    Veltri, Enzo
    Vaccaro, Angela
    Ferrari, Laura
    De Tursi, Michele
    Tinari, Nicola
    Grassadonia, Antonino
    Greco, Filippo
    Botticelli, Andrea
    La Verde, Nicla
    Zamagni, Claudio
    Rubino, Daniela
    Cortesi, Enrico
    Magri, Valentina
    Pomati, Giulia
    Scagnoli, Simone
    Capomolla, Elisabetta
    Kayal, Ramy
    Scinto, Angelo Fedele
    Corsi, Domenico
    Cazzaniga, Marina
    Laudadio, Lucio
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 7708 - 7717
  • [45] A real-world evidence study of patients with hormone receptor-positive locally advanced or metastatic breast cancer at primary diagnosis
    Bastiaannet, E.
    Charman, J.
    Johannesen, T. Borge
    Schrodi, S.
    Siesling, S.
    Van Eycken, L.
    Walsh, P. M.
    Audisio, R. A.
    Boelens, P. G.
    Van de Velde, C. J. H.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S107 - S108
  • [46] RENATA study-Latin American prospective experience: clinical outcome of patients treated with palbociclib in hormone receptor-positive metastatic breast cancer-real-world use (vol 14, 1058, 2020)
    Petracci, Fernando
    Abuin, Gonzalo Gomez
    Pini, Alejandra
    Chacon, Matias
    ECANCERMEDICALSCIENCE, 2020, 14
  • [47] Palbociclib in Hormone Receptor Positive Advanced Breast Cancer
    Vozy, A.
    Delaloge, S.
    ONCOLOGIE, 2016, 18 (01) : 79 - 80
  • [48] Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Morikawa, Aki
    Henry, N. Lynn
    CLINICAL CANCER RESEARCH, 2015, 21 (16) : 3591 - 3596
  • [49] Efficacy of chemotherapy after hormone therapy for hormone receptor-positive metastatic breast cancer
    Mori, Ryutaro
    Nagao, Yasuko
    SAGE OPEN MEDICINE, 2014, 2
  • [50] Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
    Kahraman, Seda
    Erul, Enes
    Seyyar, Mustafa
    Gumusay, Ozge
    Bayram, Ertugrul
    Demirel, Burcin Cakan
    Acar, Omer
    Aksoy, Sercan
    Baytemur, Naziyet Kose
    Sahin, Elif
    Cabuk, Devrim
    Basaran, Gul
    Paydas, Semra
    Yaren, Arzu
    Guven, Deniz Can
    Erdogan, Atike Pinar
    Demirci, Umut
    Yasar, Alper
    Bayoglu, Ibrahim Vedat
    Hizal, Mutlu
    Gulbagci, Burcu
    Paksoy, Nail
    Davarci, Sena Ece
    Yilmaz, Funda
    Dogan, Ozlem
    Orhan, Sibel Oyucu
    Kayikcioglu, Erkan
    Aytac, Ali
    Keskinkilic, Merve
    Mocan, Eda Eylemer
    Unal, Olcun Umit
    Aydin, Esra
    Yucel, Hakan
    Isik, Deniz
    Eren, Onder
    Uluc, Basak Oyan
    Ozcelik, Melike
    Hacibekiroglu, Ilhan
    Aydiner, Adnan
    Demir, Hacer
    Oksuzoglu, Berna
    Cilbir, Ebru
    Cubukcu, Erdem
    Cetin, Bulent
    Oktay, Esin
    Erol, Cihan
    Okutur, Sadi Kerem
    Yildirim, Nilgun
    Alkan, Ali
    Selcukbiricik, Fatih
    FUTURE ONCOLOGY, 2023, : 727 - 736
12345